Subject | Age | Gender | Education, years | Medication | MMSE | ADAS-Cog | APOE genotype | Amyloid PET |
---|---|---|---|---|---|---|---|---|
LD_01 | 59 | M | 9 | Donepezil 5 mg | 21 | 19 | e3/e4 | Positive |
LD_02 | 65 | F | 12 | Donepezil 10 mg | 26 | 19 | e3/e3 | Positive |
LD_03 | 63 | F | 12 | Donepezil 10 mg | 25 | 16 | e4/e4 | Positive |
HD_01 | 60 | M | 18 | Donepezil 10 mg | 18 | 20 | e3/e4 | Positive |
HD_02 | 76 | F | 12 | Donepezil 7.5 mg | 17 | 27 | e3/e3 | Positive |
HD_03 | 50 | F | 14 | Rivastigmine 9.5 mg/24 h | 14 | 29 | e3/e3 | Positive |
HD_04 | 66 | F | 6 | Memantine 10 mg, donepezil 10 mg | 24 | 19 | e3/e4 | Positive |
HD_05 | 53 | F | 16 | Donepezil 10 mg | 24 | 13 | e3/e3 | Positive |
HD_06 | 73 | M | 12 | Rivastigmine 9.5 mg/24 h | 21 | 29 | e4/e4 | Positive |